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ABSTRACT
Biomechanics of Corneal Wound Healing
The re-establishment of tissue continuity, function, and mechanical proper
ties after a through-and-through incision is an important issue in corneal
surgery and trauma. Variations in healing can affect vision and patient activ
ity during the recovery period, which may last up to five years.
Growth factors introduced into the open wound have the potential to
speed up the wound-healing process. The current investigation is con
cerned with quantitatively characterizing the mechanical properties of
corneal tissue and evaluating the effects of epidermal growth factor (EGF),
insulin-like growth factor (IGF), and platelet-derived growth factor (PDGF)
on accelerating the wound-healing process as compared to a control
group treated with phosphate-buffered saline (PBS).
A 30 day topical application period was employed to assess the influence
of EGF, IGF, and PDGF versus PBS treated corneas following through-and-
through incisions. Corneal test specimens were harvested at 3, 10, and 30
days postoperatively and subjected to uniaxial tension loading (perpen
dicular to the wound) with load and displacement values recorded. Gross
strength properties of fracture toughness, peak tangent modulus, and peak
stress were calculated and the stiffness characteristics of the test specimens
were obtained through curve fitting of the stress - stretch ratio profile.
Comparison of strength properties indicated that IGF application en
hanced peak stress, tangent modulus, and fracture toughness at 3 and 10
days while EGF application produced dominant responses at 30 days.
Stiffness characterization revealed enhanced stiffness with EGF at 3 and 30
days, while PDGF treatment showed dominant stiffness characteristics at 10
days. The results suggest that select growth factors may preferentially aug
ment the time course of corneal wound healing.
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1. INTRODUCTION
1 . 1 Overview
Wound healing is an important issue in corneal surgery and trauma where
the reestablishment of tissue continuity and function is of central importance.
Variations in healing can affect the refractive characteristics of the cornea
(27). The loss of strength at the wound and its progressive return will affect
patient activity during the recovery period (27). The effect of growth factors
in speeding up the healing process in corneas subject to through and
through incisions is the topic of this report.
The time course of skin wound healing has been documented (4,21,23)
along with the general phases of healing involved in the process (4).
However, documentation regarding the time course of corneal wound
healing and the influence of growth factors in augmenting this time course is
only lightly covered in the open literature.
A quantitative characterization of corneal tissue from an engineering stand
point was necessary for qualitative comparisons of the growth factor appli
cations. The idea of pseudoelasticity was utilized to describe the stress
stretch ratio curve obtained from uniaxial tension tests of cornea specimens,
which likewise quantify the stiffness characteristics of thewound.
An acceleration in the return of normal mechanical properties to corneal
wounds through the use of growth factors would be a breakthrough of
major importance. Research of this kind may be very beneficial in the field
of medicine with effects reaching beyond that of corneal wound healing.
The remainder of this paper is dedicated to detailing the wound-healing
process, use of growth factors, and the quantitative characterization of
wound healing.
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1 .2 Literature Review
Gasset and Dohlman (13) document the time course (up to 100 days) of
the tensile strength of several different types of corneal wounds. The tensile
strength of cornea is attributed to the length and the organization of poly
merized collagen within the fibrils, with the cross-linking mechanisms and ar
chitectural pattern of the fibers being more important than the amount of
collagen present (4,6,9,13,20). The first three weeks post injury is the time of
greatest histochemical and histological activity (20,28). Gasset and
Dohlman (13) demonstrate that by 100 days the strength of a corneal
wound was only 50% that of a normal cornea.
Augmentation of the time course in corneal wound healing has been lightly
investigated previously. Epidermal growth factor has been conclusively
shown to accelerate corneal wound healing in rabbits (17,18,19,22,25,29).
Maurice (20), noting corneas lack of blood vessels and the multitude of
growth factors released by platelets, speculates on the potential positive
effects of blood elements introduced into an open wound. However, the
quantitative assessment of platelet-derived growth factor and other growth
factors has not yet appeared in the open literature. Further discussion of
wound healing from general and cornea specific aspects is conducted in
the next Section.
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2. INTRODUCTION TO WOUND HEALING
2.1 General Wound Healing
Wound healing has been the subject of much research, particularly docu
menting the time course of wound strength from histological and strength
perspectives.
The wound healing process has been described, in a simplified form, as
possessing three main overlapping phases (4) (see Figure 1):
1 .) Inflammation (early and late)
2.) Granulation tissue production
3.) Matrix formation and remodeling
The following will briefly describe each phase. A flow-chart of significant
healing phases and subphases is depicted in Figure 2.
2.1.1 INFLAMMATION
The early inflammatory response is characterized by a series of events start
ing with blood vessel disruption which leads to extravasation1 of blood con
stituents and concomitant
platelet2
aggregation, blood coagulation, gen
eration of
Bradykinin3
and
complement4 derived anaphylatoxins5 (4). The
activated platelets release numerous biologically active substances that
promote cell migration and growth into the site of injury. Intrinsic activities of
blood vessel endothelium6 limit the extent of platelet aggregation and
blood coagulation to the wounded area.
1 The escape of fluids into the surrounding tissue.
2 Small, anuclear blood cells.
3 Plasma polypeptides possessing considerable biological activity, capable of increas
ing blood flow in, and the permeability of, small blood capillaries.
4 The term complementencompasses a group of plasma proteins that, when appropri
ately activated, bring about responses that defend the body against injury.
5Anaphylatoxins increase vascular permeability.
6 A form of squamous (flat, scaly cells) epithelium consisting of flat cells which line the
blood and lymphatic vessels, the heart, and various other body cavities.
Page 4
B
early phase late phase wound
contraction
collagen
accumulation
<9
OJ
c
o
a
(O
<B
CC
E
3
e
'><
"o
0.1 0.3 1 3
Time (days)
10 30 100
Phases of wound repair. Healing of a wound has been arbitrarily divided into three
phases: (A) inflammation (early and late), (B) granulation tissue formation, and (C) matrix forma
tion and remodeling. These phases overlap considerably with one another and are plotted along the
abscissa as a logarithmic function of time. Inflammation is divided into early and late phases
denoting neutrophil-rich and mononuclear cell-rich infiltrates, respectively. The magnitude of
wound contraction parallels granulation tissue formation, as indicated. Collagen accumulation
actually begins shortly after the onset of granulation tissue formation, continuing throughout the
phase of matrix formation and remodeling.
Figure 1 : Time Course of Skin Wound Healing (4)
Tissue
Injury
Cell Activation
or
Cell Death
Blood
Vessel
Disruption
Leukocyte Influx
- Neutrophils
Monocytes
Extravasation
Platelet Activation
Coagulation
I 1
Growth
Factors
~*
ADP
Thrombin
a Granules
^
Fibroplasia Neovascularization
(where appropriate)
Wound
Closure
Solid lines : Direct influence
Dashed lines : Influence depending on growth factor
Page 5
Inflammation
(Early Phase)
Anti infective
Coagulative
Inflammation
(Late Phase)
Cell Migration
Growth Promotion
Granulation
Tissue
Production
and
Matrix
Formation and
Remodeling
Epithelial
Reformation
Figure 2 : The Wound Healing Process. (Based on information from (4,16))
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Cell activation or death at a wound site induces an influx of inflammatory
leukocytes7
and increases the permeability of undamaged vessels adja
cent to the injured area resulting in more widespread leakage of
plasma8
proteins. The first leukocytes observed infiltrating an area of inflammation
and injury are neutrophils which are shortly followed by monocytes (4). Both
are attracted by a variety of chemotactic factors. The function of neu
trophils in an injury site is to rid the area of bacterial contamination, while the
influx of monocytes and their conversion to macrophages is seen as critical
to the initiation of tissue repair. Clark (4) makes reference to an arbitrary divi
sion made between the early and late phases of inflammation occurring
as neutrophil infiltrate resolves and macrophage accumulation continues.
The late phase of inflammation is a continued period of macrophage ac
tion. Tissue macrophages, in addition to functioning like neutrophils, phago-
cytose effete neutrophils and also release biologically active substances.
Peripheral blood monocytes continue to infiltrate the wound site progres
sively exhibiting the
phenotype9
of macrophages. Platelets release
adenosine diphosphate (ADP), facilitating coagulation, generating more
thrombin, while ADP and thrombin recruit additional platelets. Several ad
hesive proteins are released when platelets discharge a granules including:
1 .) Fibrinogen
2.) Fibronectin
3.) Thrombospondin
4.) Von Willebrand factor VIII
Growth factors are released concomitant with the release of a granules.
Platelet fibrinogen, once converted to fibrin by thrombin, adds to the fibrin
clot and both fibrin and fibronectin act as a provisional matrix for the influx of
monocytes (critical to initiation of tissue repair) and
fibroblasts10
, a major
component of granulation tissue.
'White blood corpuscles.
8 Blood plasma consists ofwater in which numerous chemical compounds, both solids
and gases, are dissolved.
9 The outward, visible expression of the hereditary constitution of an organism, traits.
10 Cells from which connective tissue is developed.
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Macrophages have a pivotal role in the transition between wound inflam
mation and wound repair. Macrophages and platelets produce growth
factors and other substances crucial to initiation of granulation tissue forma
tion.
Blood clotting may be considered a part of the inflammatory response,
since Hageman factor (HF) activation leads to Bradykinin generation and
initiation of a classic complement cascade11. Blood clotting occurs through
one of three major routes:
1 .) HF is activated by adsorption onto fibrillar collagen or other
suitable surfaces and induces an intrinsic (3,4) coagulation
system.
2.) Factor VII, activated by tissue procoagulent factor found in
interstitium and released from damaged cells induces an
extrinsic (3,4) coagulation system.
3.) Platelets and endothelial cells activated by low levels of
thrombin and platelets activated by contact with fibrillar col
lagen express coagulation factors and phospholipids that
facilitate clotting.
The inciting event of clotting is the expression of a surface that promotes ad
sorption and activation of specific coagulation proenzymes.
2.1.2 GRANULATION TISSUE PRODUCTION
Granulation tissue consists of a dense population of macrophages, fibrob
lasts, and neovasculature12 embedded in a loose matrix of collagen13 , fi
bronectin, and hyaluronic acid (HA). The process of formation of granula
tion tissue includes the accumulation of macrophages, ingrowth of fibrob
lasts, deposition of loose connective tissue, and angiogenesis14 (4).
"The classic complement cascade is a chemical reaction involving distinct proteins.
12New blood vessel formations.
13 A fibrous insoluble protein found in connective tissue. Collagen represents about 30%
of the total body protein.
14 The development of new blood vessels.
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Fibroblasts proliferate and migrate into the wound space, undergoing an
alteration of their cell phenotype, thus permitting cell motility and concomi
tant deposition of of loose extracellular matrix (ECM). These fibroblasts also
align themselves and newly-deposited matrix along the radial axes of the
wound forming cell-to-cell and cell-to-matrix links. This linkage enables a
tension resulting in wound contraction. This matrix also provides a substrate
upon which macrophages, new blood vessels, and more fibroblasts can
migrate into the wound.
It should be noted that macrophages, fibroblasts, and blood vessels move
into the wound space as a unit affirming interdependence. As fibroblasts
move into the wound space they deposit loose ECM initially composed of
large quantities of fibronectin. Fibronectin has several properties that aid in
the formation of granulation tissue including the capacity to bind connec
tive tissue cells and ECM simultaneously. The ability for cells to rapidly ad
here to, and detach from, fibronectin substratum and the fibronectin matrix
allows for fibroblast movement over a surface. Wound contraction has
been ascribed to actin-rich myofibroblasts which are the most numerous
cells in granulation tissue. These myofibroblasts are typically found aligned
along the lines of contraction.
Peripheral blood monocytes activated by inflammatory macrophages es
tablish a situation for continual synthesis and release of growth factors.
Platelets are the first cell component to release substantial amounts of pre
formed growth factors into the wounded area including Platelet-derived
growth factor (PDGF), Epidermal growth factor (EGF), Fibroblast growth fac
tor (FGF), and Transforming-growth factor type a or type p (TGF - a, TGF - p)
(more information on growth factors is introduced in Section 2.3).
Neovascularization occurs simultaneously with
fibroplasia15 through capillary
buds that sprout from blood vessels adjacent to the wound and extend into
the wound space. Blood vessel growth is suspected to depend on the
15 Formation of fibrous tissue.
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following phenomena (4):
1 .) Phenotype alteration (endothelial cell)
2.) Stimulated migration
3.) Mitogenic stimuli
4.) An appropriate extra cellular matrix
5.) A free edge defect
Endothelial cells adhere avidly to fibronectin, therefore blood vessel fi
bronectin may act as a contact guidance system for endothelial cell
movement at the tip of capillary buds (4).
Epithelial reformation re-establishes the protective barrier of the tissue to
withstand infection and dehydration.Re-epithelialization is considered with
granulation tissue development since both processes represent new tissue
generation and since re-epithelialization and granulation tissue growth
occur synchronously. Re-epithelialization begins with the movement of ep
ithelial cells from the free edge of the wound across the defect. These cells
have previously undergone marked phenotypic alteration allowing for mo
bility and the motor apparatus for motility. It is interesting to note that in cuta-
neum16, cells move in a leapfrog fashion while in the cornea, cells move in a
single file with the lead cells remaining in the lead (4).
2.1.3 MATRIX FORMATION AND REMODELING
Remodeling is the replacement of temporary fibrils with new fibrils that corre
spond more closely with the diameter and organization of normal tissue.
Structural support and strength in new tissue is provided by collagen.
Collagens are a family of closely related triple-chain glycoproteins that are
found in ECM. There are at least three types of collagen found in
connective tissue:
1 .) Fibrillar, which have uninterrupted triple helices (type I, type II,
and type III).
16 Skin.
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2.) Basement membrane collagen which has an uninterrupted
triple helix and forms a meshwork in the lamina densa of
membranes (type IV).
3.) Other interstitial collagens with interrupted helices (type V).
The process of matrix formation and remodeling occurs and begins simulta
neously with granulation tissue formation. Remodeling is the term used to
describe the period when the matrix is altered with rapid elimination of fi
bronectin and the slow accumulation of large fibrous bundles of collagen
(type I) which provides the residual scar with increasing tensile strength (4).
The geometry of the collagen network will determine the mechanical
properties of the wound. Collagen fiber diameter increases with time post
wounding and is related to tensile strength. It should be noted that for cuta
neous tissue the maximum strength of the scar tissue is only 70% as strong as
intact skin (4).
Extra cellular matrix is deposited first at the wound margin along with the ini
tial development of granulation tissue and more centrally as granulation tis
sue grows into the wound space. The composition and structure of granula
tion tissue ECM depends on the elapsed time since injury and the distance
from the wound edge.
The initial deposits of ECM contain large quantities of fibronectin. Fibronectin
plays a critical role during the formation of granulation tissue, also in matrix
formation and remodeling. Fibronectin may serve as a template for fibrillar
collagen deposition (4). Fibrillar collagens form fibrous bundles that greatly
enhance tissue tensile strength.
Hyaluronic acid is a linear polymer occurring in early granulation tissues
playing a critical role in fibroblast proliferation (4). HA appears, during mor
phogenesis, at times of cell movement and mitosis and disappears at the
onset of differentiation. As granulation tissue matures, HA is replaced by sul
fated glycosaminoglycans (GAGs, proteoglycans) that provide the tissue
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with more resilience but accommodate cell movement and proliferation
less well. GAGs are a prominent component of the interface between ep
ithelium and mesenchyme17, which play a critical function during wound re
pair with regard to re-epithelialization and angiogenesis. Therefore the
early matrix consisting of fibronectin and HA, which was conducive to cell
migration and proliferation, is converted to a collagen and proteoglycan
matrix that increases the tissue tensile strength and resilience.
2.2 Corneal Wound Healing
Figure 3 is a cross section of an eyeball. The first step in sight is when light en
ters the eye through the cornea which is subsequently focused by the lens
onto the retina. Light is able to pass through the cornea, in part, because of
its avascularity18 .
The cornea consists of three principal layers (see Figure 4):
1 .) Epithelium
2.) Stroma
a. Anterior lamina
b. Substantia propria corneae
c. Posterior elastic lamina
3.) Endothelium
The overall anatomy of the cornea is depicted in Figure 4 for a specimen
taken near the margin, or juncture tissue between cornea and sclera.
The epithelium is composed of stratified squamous cells and serves as a
barrier covering the front of the cornea and functions to transport fluids into
and out of the stroma.
Ordered from exterior to interior, the stroma, which makes up 85% to 95% of
the corneal thickness, is further composed of three sub-layers. The anterior
lamina, also known as Bowman's membrane, consists of closely interwoven
fibrils containing no corneal corpuscles (modified fibroblasts) and is
17 A diffuse network of cells giving rise to connective tissues.
18 Lack of blood vessels.
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Figure 3 : Cross Section of Eye. (Adapted from Gray's Anatomy, 29th American
Edition, 1973, ed by Goss, CM., Lea & Febiger, Philadelphia, page 1045]
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Vertical section of human cornea from near the margin. (Waldeyer. ) Magnified. 1. Epi
thelium. 2. Anterior lamina. 3. Substantia propria. 4. Posterior elastic lamina. 5. Endothelium of the
anterior chamber, a, Oblique fibers in the anterior layer of the substantia propria, b, Lamellae, the fibers
of which are cut across, producing a dotted appearance, c, Corneal corpuscles appearing fusiform in
section, d, Lamellae, the fibers of which are cut longitudinally, e, Transition to the sclera, with more
distinct fibrillation, and surmounted by a thicker epithelium, f, Small blood vessels cut across near
the margin of the cornea.
Figure 4 : Cross Section of Cornea. (Adapted from Gray's Anatomy, 29th American
Edition, 1973, ed by Goss, CM., Lea & Febiger, Philadelphia, page 1051)
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regarded as a condensed part of the substantia propria. The substantia
propria corneae is a fibrous, tough, and unyielding transparent layer of
roughly 60 flat superimposed lamellae made up of bundles of modified
connective tissue. Corneal spaces contain corneal corpuscles. The poste
rior elastic lamina, also known as Descemets membrane, is an elastic, trans
parent, homogeneous membrane of extreme thinness covering the poste
rior surface of the substantia propria corneae.
Endothelium is a single mesothelial19 layer covering the posterior surface of
the elastic lamina functioning both as a barrier (through the restriction of
movement of fluid from the aqueous humor into the hydrophilic stroma)
and as a pump (effecting ion-coupled fluid transport in a direction opposite
to that of the fluid leak). Endothelium has little or no regenerative capability,
therefore corneal transplantation is the only current method for replace
ment of damaged or diseased endothelium (14,18).
In the eye, wound closure and healing following corneal wounding in
volves a complex series of events in both the epithelium and the stroma.
Maurice (20), in his review of skin wound healing, noted that many of the
processes are common between the skin and the cornea. The roles of
monocytes, their transformation into fibroblasts, and the lining of the wound
edges with fibronectin are also of importance in the corneal wound-heal
ing cycle.
The corneal wound healing phase analogous to granulation tissue produc
tion in the skin similarly consists of a dense population of macrophages and
fibroblasts of which keratocytes20 are a major supplier (5,20). Damaged fib
rils are digested and replaced with new less organized ones during this
phase.
19 Forms the simple squamous epithelium that covers the surface of all true serous mem
branes.
20The mesenchymal cells of the cornea.
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2.2.1 EPITHELIAL RESPONSE
Epithelial wound closure occurs through the migration of the remaining ep
ithelial cells surrounding the defect area and the formation of an epithelial
plug (5). Two phases have been characterized in this closure, the latent
and the healing. The latent phase is when the cellular and subcellular reor
ganization of cells occur, and the healing phase is when the closure of the
wound occurs at a steady rate through a single layer of motile cells. These
phases correspond to the inflammation and granulation-tissue-production
phases of skin wound healing.
2.2.2 STROMAL RESPQNSF
It is known that in the initial stages of healing, the epithelium migrates into the
tract of the stromal wound space forming an epithelial plug which retracts
as the stromal scar is formed. The role of stroma in the healing of a corneal
wound has not been fully characterized in the open literature.
2.2.3 ENDOTHELIAL RESPONSE
The initial response of the endothelial monolayer to wounding is the activa
tion of the surviving endothelial cells to surround the wound area, these cells
then enlarge, flatten, and migrate to the damaged area (14). Three stages
in endothelial wound healing have been identified (14). In stage 1 the
wound site becomes covered by spindle shaped cells with the corneal
thickness being at a maximum. Endothelial pump site density is at a mini
mum and the new endothelial barrier begins to form. Stage 2 shows the ini
tiation of an intact and contact - inhibited (1 4) monolayer where cells flat
ten, become polygonal and form junctional complexes. Endothelial per
meability and pump site density return to normal, resulting in corneal thick
ness experiencing its greatest decrease. Stage 3 is a continuation, despite
prior normalization of endothelial function, of morphologic remodeling and
decreasing corneal thickness.
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2.3 Growth Factors
Traditional cell culture techniques continue to evolve with the discovery of
the growth promoting effects of certain proteins on different cells. The
growth of normal cells is typically controlled by a variety of substances, in
cluding a group of polypeptide growth factors which are hormone - like
agents in both function and structure. Growth factors are all polypeptides
that exert their biological information through specific membrane
receptors21. Certain growth factors affect specific cells differently than others,
and some growth factors are species specific, while others are not.
2.3.1 EPIDERMAL GROWTH FACTOR (EGF)
Epidermal growth factor can be obtained from mouse submaxillary glands
and has been identified in various human tissues and fluids including urine,
saliva, plasma, and breast milk. EGF can also be synthesized using recom
binant DNA techniques.
Epidermal growth factor has been shown to enhance growth and matura
tion of organ cultures of epithelial tissues, accelerate the epithelial healing
rate in non-penetrating scrape wounds and to increase wound strength
after full-thickness stromal incisions (16,17,18,19,22,25,29). EGF has been ob
served as a potent mitogen for fibroblasts and can stimulate or inhibit
proliferation or differentiation of a wide variety of cells. EGF enhances the
wound strength of full-thickness corneal wounds in a dose-dependent man
ner (19).
Epidermal growth factor receptors are found on corneal epithelium, en
dothelium, conjunctiva22 and the posterior pigmented layer of the iris and
the lens epithelium.
21 Receptors are groups of cells functioning in reception of stimuli.
22The mucous membrane of the eye lining the inner surface of the eyelids, reflected
over the anterior part of the sclera.
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2.3.2 INSULIN - LIKE GROWTH FACTOR (IGF I. IGF II)
Insulin-like growth factors, so named for producing insulin-like actions, are
polypeptides obtained from human plasma. IGF's link (without inducing)
growth hormone and the stimulation of metabolic processes leading to cell
proliferation. IGF's have been characterized as a mitogenic stimulus for
multiple cell types (16,18).
2.3.3 PLATELET DERIVED GROWTH FACTOR (PDGF)
Platelet-derived growth factor plays a role in the normal tissue repair pro
cess. It has been shown to be chemotactically active for human mono
cytes, neutrophils, smooth muscle cells, and fibroblast activities related to tis
sue inflammation and repair following wounding (16).
2.4 Significance of Research
Rapid return of normal mechanical properties is one of the primary goals of
wound repair. The acceleration of the naturally-occurring wound healing
process is an important issue in corneal surgery, trauma, and infection.
Variations in healing can affect ocular refractive characteristics, and the
strength of the wound will have an effect on patient activity during the re
covery period. Under normal circumstances, human corneal wound heal
ing is considerably slower than in some animals.
Growth factors play important roles in inflammation and wound healing in
cutaneous tissue repair. It is therefore logical to investigate the potential of
growth factors in promoting corneal wound healing. The focus of the re
search documented herein is to quantify the biomechanical properties of
corneal tissue during healing following a through-and-through incision. The
biomechanical properties will be used to assess whether growth factors
such as EGF, IGF, and PDGF can accelerate corneal wound healing versus
normal controls treated with phosphate buffered saline (PBS).
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3. MECHANICAL CHARACTERIZATION OVERVIEW
It is well known that many biological tissues, including cornea, exhibit hys
teresis when subjected to cyclic loading and unloading (10). When held at
a constant strain (defined as the ratio of the total deformation over the origi
nal length), stress relaxation in the tissue occurs (decreasing reaction load)
and when held at a constant stress (defined as the force per unit area, in
axial loading the magnitude of the applied force divided by the cross sec
tional area), the tissue exhibits creep (continued elongation stress). Strain
relationships for biological tissues are generally nonlinear with the material
properties exhibiting directional sensitivity (anisotropy).
3.1 Pseudoelasticity
For many problems involving finite deformation of biological tissue it is con
venient to use constitutive equations relating stresses to finite strains. It is also
convenient to compare material constants involved in the constitutive
equations in order to assess changes in mechanical properties.
For preconditioned tissues (tissues subjected to the loading - unloading
cycle until the stress -strain relationship is well defined, repeatable, and pre
dictable) the stress - strain relationship is unique for the loading branch and
the unloading branch separately. Thus the material can be treated as one
elastic material in loading and another elastic material in unloading, and
the theory of elasticity can be employed to handle each material during its
respective load/unload regime. This analysis approach is termed "pseu
doelasticity". Pseudoelasticity , while not an intrinsic property of the material,
is a convenient description of the stress strain relationship during loading or
unloading (12).
Fung (12) elaborates on the usefulness of the concept of pseudoelasticity
extolling its virtue of relative strain rate insensitivity. For our study, a constant
strain rate was used throughout the experiments to limit rate-dependent ef
fects, such as dissipation.
I-l:= X2 + 2/X
I2 = mx2 + 2^
13-= 1
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3.2 Postulated Analytical Model
Several mathematical formulas were reviewed to characterize the stress -
stretch profile of our specimens subject to uniaxial extension. Previous work
(7,8,15,24) on highly elastic material suggest that the strain energy, hence
stress strain relation, depends on the strain invarients i-,, i2, and i3 which
are defined through material geometric stretch ratios. Under the assump
tions of isotropy, homogeneity, and incompressibility, the following strain in
varients for soft biological tissues were defined by Demiray (7,8) for uniaxial
extension:
(1.)
where X is the stretch ratio (stretch ratio = strain + 1) in the axial direction (X^),
defined as the deformed length divided by the original length (see Figure
5). i3 = 1 reflects the incompressibility assumption for the tissue. This formula
tion corresponds with that of Rivlin and Saunders (24), and Kao and
Razgunas (15). It should be noted that in the undeformed state X^ =X2 = X3
= 1 such that i1 = i2 =3.
After review and trial and error it was decided that the following quantifica
tion would best suit our needs. This decision was based on factors dis
cussed in Sections 4.2.2 and 5. 1 . Fung (1 0) postulates a uniaxial stress stretch
ratio relation as:
o=C(exp(B?i))-A (2.)
where o is stress, X is the stretch ratio in the axial direction, with parameters A,
B, and C determined experimentally.
Page 20
Taking this a step further, C can be determined by finding a reference point
on the curve, say 0 =
0*
when X = X*. Therefore (1 0):
a=(a*
+ A)exp(Ba-r))-A (3.)
Note: if X is referred to the natural state, we must have by definition, a = 0
when X = 1 . This is only possible if:
A = a*exp(B(1 -r))/{1 exp(B(1 -X*))} (4.)
The slope of the stress - stretch ratio curve defined in equation (3.) can be
examined by differentiating (3.) with respect to X. This yields, after manipula
tion:
doldX = D(exp(B^)) (5.)
where
D = (o* + A)B/exp(Br ) (6.)
Note that a* and X* are reference parameters and hence variations in
material parameters A and B are incorporated in the definition of D and
equation (6.). The rate of load bearing with increments in stretch ratio can
be assessed through comparison of both B and D material parameters.
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Xi =ULo
Xz = d/do
X.3 = W/W o
Figure 5 : Stretch Ratio Definition
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4. METHODOLOGY
4.1 Experimental Protocol
An/n vivo animal model was determined to be the appropriate approach
for this research since it would allow the knowledge gained to be applied
to humans in the clinical situation. All animals used in this study were treated
in accordance with the ARVO Resolution on the Use of Animals in Research.
The surgical and specimen preparation described in Sections 4. 1 .1 and 4.1 .2
were conducted by research colleagues at the University of Rochester
Cornea Research Laboratory (27).
4.1.1 Wounding Procedure (27)
White New Zealand rabbits were put under general anesthesia using intra
venous sodium pentobarbital (30 mg / kg) with local reinforcement admin
istered preoperatively (Topical Proparacaine drops). After the animals
were found to be appropriately anesthetized, nictating membranes were
cut bilaterally and with the aid of a Zeiss operating microscope (Carl Zeiss,
Inc., Thomwood, NY) the rabbits received full thickness incisions, made with
a saphire knife, on both corneas in an approximately six mm straight line run
ning horizontally. Collagen shields were placed on both eyes with the right
eye shield presoaked in growth hormone and the left eye shield pre-
soaked in saline. Collagen shields were removed after 24 hours. Each day
animals received one drop of gentamycin in both eyes, phosphate
buffered saline (PBS) drops in the left eye (control) and the proper growth
hormone in the right, all given three times daily (TID). Growth hormones
(EGF, IGF, PDGF) were administered in concentrations of 1 00 mg / kg.
Precautions were taken to minimize wound contamination and postopera
tive infection (including conjunctival infection and exudate) including
cleansing the periorbital skin around the eyes with betadine solution preop
eratively and the administration of bentamycin eye drops, one drop twice
daily (BID) in both eyes beginning immediately after the procedure and
continuing until seven postoperative days. Animals were killed with an intra-
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Crosshead Grips
Figure 6 : Sketch of Mounted Specimen
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Figure 7 : Sketch of Test Set-Up (27)
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Voltage was easily converted to force (kg) using the formula:
volts x full scale range (.1 , .2, or .5 volts) / 10 (7.)
A simultaneous videotape record of the deformation time course was
made with the load cell output voltage superimposed. The data from the
strip chart and videotape were used to calculate tissue geometry, maxi
mum wound strength, peak tissue stiffness, and tissue fracture toughness (the
test set-up is shown in Figure 7). Video data were digitized and used to de
termine tissue load - deflection diagrams suitable for curve-fitting to the ana
lytical model outlined in Section 3.3
4.2 Analysis Protocol
The videotaped record of the deformation time course in combination with
the strip chart data provided sufficient information for analysis.
4.2.1 VIDEO DIGITIZING
The main tool used for video digitizing and analysis was the JAVAtm version
1.20 (Jandel Scientific, Corte Madera, CA) software operating on an IBM
PS/2 Model 30-286 personal computer, JVC HR - D670U Video Cassette
Recorder, a Panasonic WV - 3240 Video Camera, and a Panasonic CT -
1330 M monitor. The image analysis system contained in this software had
several features ideally suited for our purposes including The Frame
Grabber, Morphometric Measurement, and The Data Worksheet.
The Frame Grabber (video digitizing) creates a junction among the hard
ware elements of JAVA: the camera (or VCR), the video monitor, and the
computer. The ability of this software to freeze (grab and store) an image
from a stream of images by converting the frame to a set of digital values
lends itself to manipulation and measurement.
The Morphometric Measurment system utilizes the x and y locations of the
video monitor pixels (discreet cells) to form the basis for geometric mea-
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Figure 8 : Typical Load-Deflection Curve (27)
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Figure 9 : Typical Data Segment for Curve Fitting Prior to Conversion to Stress
Along Ordinate and Stretch Ratio Along Abscissa
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4.2.2 STRESS - STRETCH RATIO CHARACTERIZATION
Another software package, ASYSTANT 1.1 (Asyst Software Technologies Inc.,
Rochester, NY) operating on an IBM PS/2 Model 30-286, was used exclu
sively for compliance characterization via curve-fitting stress stretch ratio
data obtained when each specimen was loaded.
Curve fitting is simply the application of a quantitative relationship containing
a number of parameters to a set of paired x and y (y depending on x)
data in order to represent that data at infinite x locations within the range of
the original x data. The experimental stress - stretch ratio data is specified as
Xj (stretch ratio) and yj (stress) data pairs at the ith location over n discreet
values of stretch ratio. A typical data segment used in this phase is shown in
Figure 9 which is recognized as a subset of the data depicted in Figure 8.
The two main steps involved in curve fitting are the choice of the quantita
tive relation and the adjusting of the fit parameters until a "best
fit" is ob
tained. The goodness of the fit can be determined from three values
computed by ASYSTANT: the sum of the squared residuals (Err2), the square
of the multiple correlation coefficient (R2), and the significance of fit (Sig)
which is computed by applying an F-test to the multiple correlation coeffi
cient. Mathematical definitions of these coefficients obtained from the 1 988
ASYSTANT, Student Version, Analysis Reference manual (Asyst Software
Technologies. Inc., Rochester, NY) are shown below.
Err2 =j \V\- F[xi]l2 F = user function (8.)
i = 1
n
R2
=
1-Err2/Res2 Res2 =X \vf (9)
S'g = PF[n-m,m](f > F) F= R2(n-m)/(1 - R2)m (10.)
Page 30
Note that Err2 is merely the result of a least squares fit of a user-defined ap
proximation F(x) to the dependent data set y| at each discreet Xj.
ASYSTANT consists of a Desk Calculator that provides much of the raw-calcu
lating capabilities of the system, and a number of Main Menu Options.
Data is passed between the options through the Desk Calculator
Parameters and Variables, which provide storage of numbers and arrays,
and are always available for computation.
The Main Menu Option used for the stress stretch ratio characterization was
the Curve Fit option with a user-supplied fitting function. Data points for the
stress - stretch ratio curves were input into ASYSTANT's desk calculator storage
locations manually along with a curve-fitting function. The Gauss - Newton
algorithm contained within ASYSTANT was used to adjust the parameters until
the disparity between successive parameter modifications was small
enough to satisfy the convergence criterion which was chosen as no
change in the fifth decimal place of the R2 value.
4.2.3 DATA REDUCTION
In order to compare various experimental specimen data sets using plots
of stress versus stretch ratio, it was necessary to modify the original data val
ues of force and displacement. Stress was obtained by dividing force by
the undeformed cross sectional area at the wound site, this is termed the
engineering stress as it takes the geometric factor of original cross sectional
area into consideration. The stretch ratio is defined simply as the deformed
length divided by the original length. The stretch ratio is a dimensionless
number and is equivilant to strain + 1 .
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5. RESULTS
In order to successfully complete this project it was necessary to:
- Characterize the stress - stretch ratio curve of corneal tissue for
comparative purposes
Evaluate the effects of the growth factors on the mechanical
properties of corneal tissue
5.1 Analytical Formulation
Based on the literature review it was expected that the stress stretch ratio
curve would take on an exponential form (7,8,10,12,15,24,26). This was con
firmed through observation of our recorded data. As mentioned in Section
3.3, itwas decided that Fung's (1 0) expression:
o=(a*
+ A)exp(B(X X*)) - A (3.)
would best suit our needs. This decision was based on the ease of applica
tion, fit error, and the ease in comparison of the fitting parameters. Note that
o*
and
X,*
represent a reference point in the data set and are constant pa
rameters for a given specimen, A and B are determined from experiment,
and X, and a are known values in the data set.
From equation (3.) it was expected that the B parameter would control the
rate of curvature of the stress stretch ratio relation (i.e., as B increases so
would the rate of curvature) and that the A parameter would dictate the ini
tial slope of the curve (i.e., as A increases so would the initial slope). This ap
peared to be true in our results.
5.2 Application of Analytical Formulation
As mentioned in Section 4.2.2, ASYSTANT 1 . 1 was used to. curve fit the raw
data. Individual specimen data sets were approximated using equation
(3.) and groups of specimens based on growth factor and time period
were also approximated using equation (3.). These specimen groups al
lowed for a pooling of experimental data according to time period and
Page 32
applied growth factor such that a subsequent curve fit to these multiple
data sets produced a "composite" fitted curve (hereafter referred to as
"the composite"). Results of the composite curve fitting are contained in
Appendices A - C. A best fit for the data was chosen on the basis of change
in fit parameters and change in fit error as mentioned in Section 4.2.2.
Following Fung's protocol, a* and X* were chosen at the upper end of the
stress - stretch ratio curve (large stress in the physiological range) and varied
with specimen (10). On occasion, when fitting a data set, the fit parameters
forced the origin of the curve to a negative stress level. This, not justified
based on the experimental protocol, necessitated the use of the equation:
A = a*exp(B(1 -X*))/{1 - exp(B(1 -X*))} (4.)
to adjust the value of equation (3.) at the origin (controlled by the A param
eter) to an acceptable value. It was determined by data comparisons
before and after implementation of equation (4.) that this modification im
pacted the curve-fit results (material parameters A and B) minimally.
5.3 Fit Parameter Comparison
Stress and stretch ratio data were recorded for two different sets of fiduciary
markers, from crosshead grip to crosshead grip and from bead to bead
(see Figure 6). Limitations in the optical resolution of the video and morpho
metric measuring system made measuring the crosshead grip (referred to
as simply "the crosshead") stretch ratio considerably easier and less error
prone than that of the bead stretch ratio.
To compare fit parameters from each composite curve in a meaningful
way it was required that a
"baseline"
value for either o* or X* be chosen
(see Figure 10). The baseline parameter chosen for our experimental data
was a common (to all curves) stress level, o*. Once
a*
was set, it was possi
ble to directly read from each trace respective
X*
values (for each com
posite data set). The data set could then be re-curve-fit using
a*
and
X* to
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obtain comparable A and B parameter values (see Tables 1 and 2),
Once comparable data was derived, the time dependency of the pa
rameters and the influence of the growth factors at individual time periods
were inspected.
Review of our data indicated that the material parameters are inversely
proportional to each other; a high A value being associated with a low B
value and vice-versa.
5.3.1 Time Dependency of Curve-Fit Material Parameters
As time progressed from three to thirty days, the material constants A, B, and
D for both crosshead and bead data (for all growth factors and controls) in
creased in value (see Tables 1 and 2), signifying increasing stiffness (de
creasing compliance). There was a deviation from this trend however, for
EGF crosshead data which showed a decrease in the B parameter at
each time period yet the D value continuously increased. In all other
crosshead cases the values of A and B at thirty days were greater than re
spective values at three days. PBS crosshead and bead data and PDGF
crosshead data showed an increase in A and B values at ten days from
three days, but at thirty days both growth factors showed a decrease in val
ues of A and B from ten days. The values at thirty days were greater than
those at three days. The D value obtained from equation (6.) was useful in
helping to quantify the overall stiffness of the composite curve in cases like
these when the A and B values didn't follow the trends. Graphical represen
tations of these trends are depicted in plots contained in Appendix B.
5.3.2 Influence of Growth Factors at Time Period
Comparison of the material parameters at each time period shows that
certain growth factors enhance the speed of the healing process.
Appendix C contains graphical representations of this data. Agreement be
tween the fit parameters (Tables 1 and 2) and the tensiometry data (see
below) corroborate this observation. At 3 days EGF was shown to be the
stiffest, at 1 0 days PDGF was the stiffest, and at 30 days EGF was the stiffest.
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3 DAY BEAD COMPOSITE- DATA
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Figure 10 : Sample Curve Fitting From Baseline Parameters
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Time Growth
Period Factor a* (MPa). 2^ A (MPa) fi D (MPa}
3 Day EGF .0049 1.07 1.2598E-3 8.23868 7.53E-6
IGF .0049 1.067 2.7637E-3 12.0383 2.44E-7
PBS .0049 1.068 4.7552E-3 8.40684 1.02E-5
PDGF .0049 1.1375 -1 .0552E-4 13.9141 8.92E-9
10 Day EGF .0049 1.01 .064815 7.61427 2.43E-4
IGF .0049 1.008 .0408 12.5919 1.77E-6
PBS .0049 1.009 .075283 6.80393 5.69E-4
PDGF .0049 1.003 .44705 5.49399 .01
30 Day EGF .0049 1.002 .52673 6.353 5.81 E-3
IGF .0049 1.037 .07201 14.2958 4.01 E-7
PBS .0049 1.008 .058075 14.7388 3.28E-7
PDGF .0049 1.004 .06081 16.362 7.89E-8
Table 1 : Curve Parameters - Crosshead - Common o*
Time Growth
Period Factor a* (MPal 11 A (MPa) B D (MPa}
3 Day EGF .0049 1.094 .0581 1 .583753 .019
IGF .0049 1.105 7.8125E-3 4.05693 5.83E-4
PBS .0049 1.153 .02445 1.18336 8.87E-3
PDGF .0049 1.22 1.4E-4 5.80018 2.47E-5
10 Day EGF .0049 1.011 .10759 3.99082 5.7E-3
IGF .0049 1.001 .03627 7.88296 1.21E-4
PBS .0049 1.011 .11557 3.17028 .015
PDGF .0049 1.007 .90697 1.30662 .32
30 Day EGF .0049 1.006 .80055 2.43281 .17
IGF .0049 1.01 .18024 2.53792 .036
PBS .0049 1.005 .082968 12.9322 2.58E-6
PDGF .0049 1.005 .059617 8.81756 8.06E-5
Table 2: Curve Parameters - Bead - Common a*
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5.4 Strength Parameter Comparison
Progression of time from 3 to 30 days showed all specimens treated with
growth factors to possess increasing values of the mechanical properties of
fracture toughness, peak tangent modulus, and peak stress. Appendix D
contains graphical representations of the tensiometry results. At 3 days IGF
had the largest tangent modulus, fracture toughness, and peak stress; at 10
days IGF had consistently higher values than the control group for the tan
gent modulus, fracture toughness, and peak stress; and at 30 days EGF had
the highest values for the tangent modulus, fracture toughness, and peak
stress.
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6. DISCUSSION
The combined data of the control specimens and those specimens with
applied growth factors suggest increased stiffness and enhanced mechan
ical load bearing with time, indicative of enhanced collagen fiber forma
tion and cross-linking (27).
Previous histological examination (27) revealed that at 3 days the wound is
still mostly open, at 10 days the wound is completely closed and ap
peared to be bridged by collagen fibrils in a mostly disorganized pattern,
and at 30 days the wound was more organized with collagen fibrils falling
into the regular lamellar pattern. A triphasic time history was observed possi
bly reflecting distinct phases of corneal tissue repair analogous to cuta
neous tissue repair (27). A correlation between the histological examination
and tensiometry results may exist and may be explained through wound-
healing biology.
It is important to keep in mind that while the biomechanical effects of the
growth factors may be observed at 30 days, the growth factor may have
been biologically active at 8 days; therefore, histological examination and
a fundamental understanding of histochemical proceedings in the field of
wound healing is necessary.
Platelets play an active role in the inflammatory phase of cutaneous wound
healing, adhering to collagen and releasing adhesive proteins and growth
factors. These substances aid in clotting and are instrumental in the initiation
of granulation tissue formation. PDGF is one substance released during this
early phase in wound repair and may explain the response (stiffness and
strength) of the avascular corneal tissue to PDGF at the 1 0 day time point.
Following this line of reasoning, IGF, obtained from plasma, might also have
its response (stiffness and strength) explained in this way. Such events would
correspond with the hypothesis of Maurice (20) that introduction of blood
constituents may induce positive enhancement of overall corneal wound
healing.
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Fibroblast activity and epithelial healing rate have been observed to be
affected by EGF (17,18,19,22,25,29). Granulation tissue production and ma
trix formation and remodeling are the last two phases of cutaneous wound
healing occurring synchronously and for an indefinite time course starting
soon after day 2 (see Figure 1), analogous trends are expected in corneal
wound healing. Granulation tissue production and matrix formation and re
modeling are characterized by a dense population of fibroblasts and ep
ithelial reformation and may be the reason for the effectiveness of EGF at
the 30-day time period in our study.
6.1 Summary
Our observations suggest a triphasic time course in wound healing for
corneal tissue based on biomechanical testing and histological observa
tion. The apparent response of wound healing to different growth factors
also suggests that different growth factors may
'target'
specific healing
phases or sub-phases, thereby augmenting the wound healing process.
6.2 Recommendations
There were limitations in our experiment which may have affected the re
sults:
For our experiment there was a relatively small sample size. This may bias
any statistical analysis and affect statistical relevance. Sample sizes are
noted on the tables in the Appendices.
As can be seen in Figure 6, the location of the beads is critical for proper
measurement of the stretch ratio. A template to help locate the beads in
the same location from specimen to specimen would have simplified the
preparation of specimens and may have had an effect on the variability of
the stretch ratio of different specimens.
The morphometric measurement system is based on measuring from pixel
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to pixel. Between beads an extraneously measured pixel may bias the
measurement by nearly 3%, while between the crosshead grips measure
ment bias was only .2%.
The specimen thickness measurement was based on a calculation utilizing
the planform area, specimen weight, and tissue density:
tmean = M/Ap)/(.00101(g/mm3)) (11.)
as opposed to direct measurement. This was necessary due to the flexibili
ty of the material. However, this also introduced a possible source of error.
The stress measurement calculation utilized the original cross sectional area
of the specimen which was partially determined from this thickness mea
surement (cross sectional area = width * thickness).
Specimen size and material also indicated that strict climate control may
have been necessary to limit the effects of temperature and humidity, how
ever, a climate controlled room was not available.
The hourglass shape of the specimens also introduced error into the evalu
ated material properties. Appendix E contains finite element analyses of
both rectangular and hourglass planformed specimens showing stress con
tours. The hourglass specimens clearly exhibit stress concentrations in the
wound location, therefore, the gross strength properties of fracture tough
ness, peak stress, and tangent modulus may all be underestimated by as
much as 15% (27), the stiffness characterization may also have been affect
ed. In all tensile tests the specimen fracture initiated at the edge of the
wound, propagating across, as opposed to occurring uniformly across the
wound. The time course data and subsequent rise in wound strength prop
erties postoperatively remains qualitatively correct if hourglass planform
stress concentrations are considered. A device to prepare rectangular
specimens prior to the removal of the inherent concavity of cornea would
be beneficial to this type of research.
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The disparity between individual data sets within a composite set may have
been related to the fact that the tissue was not preconditioned. For our test
ing it was necessary to destroy the specimens in order to obtain peak
strength values, however, in the future it may be possible to precondition the
specimens utilizing known peak strengths of the tissue before recording
data to create stress - stretch ratio plots.
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APPENDIX A
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EGF Composite Curve-Fit Parameters
Time Period Location o* (MPa) XI A (MPa} B
3 Day [4] Crosshead .019122 1.215 1.25396E-3 8.29314
Bead .016671 1.39 .097534 .364868
10 Day [3] Crosshead .1417 1.156 .063813 7.66329
Bead .1177 1.185 .10836 3.97447
30 Day [3] Crosshead .9806 1.166 .5278 6.42935
Bead .5884 1.23 .79575 2.44145
[n] = number of specimens
Table 3: Curve Parameters - EGF - Composite Fitting
IGF 3 DAY CROSSHEAD DATA
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Time Period Location o* (MPa) H A (MPa) B
3 Day [3] Crosshead .01226 1.12 2.86959E-3 11.8496
Bead .01373 1.235 7.2254E-3 4.25481
10 Day [3] Crosshead .1373 1.116 .03983 12.6961
Bead .1079 1.16 .03558 7.92239
30 Day [2] Crosshead .86296 1.18 .070805 14.3246
Bead .8335 1.68 .1811 2.53419
Table 4: Curve Parameters - IGF - Composite Fitting
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Time Period Location a* (MPa) 11 A (MPa)
3 Day [4] Crosshead .01765 1.168 4.6589E-3 8.5002
Bead .01393 1.38 .02408 1.20069
1 0 Day [3] Crosshead .1814 1.18 .07584 6.78586
Bead .1667 1.28 .11751 3.15427
30 Day [3] Crosshead .5884 1.166 .05716 14.775
Bead .5884 1.13 .1319 13.0601
Table 5: Curve Parameters - PBS - Composite Fitting
PDGF 3 DAY CROSSHEAD DATA
Page 54
7.0
1.00 1.04 1.08 1.12
Stretch Ratio
1.16 1.20
PDGF 3 DAY BEAD DATA
1.00 1.05 1.10 1.15 1.20
Stretch Ratio
1.25 1.30
PDGF 10 DAY CROSSHEAD DATA
Page 55
0.70
0.60 --
C/0.50 -
cd
Oh
S 0.40 -
co 0.30 -
CD
0.00
1.00
+
1.04 1.08 1.12 1.16
Stretch Ratio
1.20
0.70
0.60 -
0.00
PDGF 10 DAY BEAD DATA
*
1.00 1.05 1.10 1.15 1.20 1.25 1.30
Stretch Ratio
1.35 1.40
PDGF 30 DAY CROSSHEAD DATA
0.50 n 1 r 1 1 1 ^r
Page 56
0.00 *
1.00 1.02 1.04 1.06 1.08 1.10
Stretch Ratio
1.12 1.14
0.50
o.oo
PDGF 30 DAY BEAD DATA
1.00 1.04 1.08 1.12 1.16
Stretch Ratio
1.20 1.24
PDGF Composite Curve-Fit Parameters
[n] = number of specimens
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Time Period Location O* (MPa) H A (MPa) B
3Day[1] Crosshead .00686 1.162 -9.6727E-5 13.8839
Bead .00686 1.275 -4.8244E-5 6.05766
10 Day [2] Crosshead .4413 1.126 .44737 5.49189
Bead .5394 1.36 .88743 1 .32735
30 Day [2] Crosshead .3923 1.122 .06064 16.3725
Bead .2942 1.198 .05951 8.82164
Table 6: Curve Parameters - PDGF Composite Fitting
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APPENDIX B
Time Course Composite Data For Growth Factors
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APPENDIX C
Composite Data Per Time Period
3 DAY CROSSHEAD COMPOSITE DATA
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APPENDIX D
Tensiometry Results
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Peak Tangent Modulus (MPa) =/- Standard Error of the Mean
Growth
Factor 3 Days 1 0 Davs 30 Davs
EGF [6] .1 71 +/- .022 [7] 1 .74 +/- .1 2 [7] 1 2.43 +/- 1 .67
IGF [3] .246 +/- .069 [6] 4.0 +/- .28 [2] 8.1 3 +/- .57
PBS [8] .201 +/- .01 6 [4] 3.33 +/- .53 [4] 1 0.51 +/- 1 . 1
PDGF [8] .2 +/- .026 [6] 2.22 +/- .31 [6] 8.85 +/- 1 .01
[n] = number of specimens
Table 7: Peak Tangent Modulus (MPa) +/- Standard Error of the Mean
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Peak Stress (kPa) =/- Standard Error of the Mean
Growth
Factor 3 Davs 10 Davs 30 Davs
EGF [6] 1 3.9 +/- 1 .87 [7] 1 45.34 +/- 1 7.62 [7] 986.57 +/- 1 41 .94
IGF [3] 17.94+/- 1.12 [6] 1 94.7 +/- 1 1 .0 [2] 680.0 +/- 225.0
PBS [8] 15.19+/- 1.23 [4] 196.3+/- 5.5 [4] 666.5 +/- 34.92
PDGF [8] 12.98+/- 1.94 [6] 160.13 +/- 30.42 [6] 747.69 +/- 85.94
[n] = number of specimens
Table 8: Peak Stress (kPa) +/- Standard Error of the Mean
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Fracture Toughness (kPa) =/- Standard of the Mean
Growth
Factor 3 Davs 1 0 Davs 30 Davs
EGF 16] 1 .95 +/- .25 [7] 17.46+/- 2.37 [7] 93.17+/- 12.31
IGF [3] 2.12+/-.39 [6] 16.45+/- 1.08 [2] 65.66 +/- 13.12
PBS [8] 1.81 8+/-.242 [4] 15.13+/- 1.01 [4] 65.08 +/- 8.2
PDGF [8] 1 .78 +/- .39 [6] 17.56+/- 3.28 [6] 76.77 +/- 11.74
[n] = number of specimens
Table 9: Fracture Toughness (kPa) +/- Standard Error of the Mean
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APPENDIX E
Finite Element Analysis of Specimen Shape
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In summary from reference (27): Figures 1 1 and 12 depict contours in load-
directed stress for each specimen planform as determined from finite
element analysis. The contour legend is depicted in each figure and has
units of grams per square millimeter. The numerical finite element analysis
employs a nominal load applied to each specimen so that a stress level of
2 g/mm2 should occur at midlength. Figure 1 1 clearly shows that
rectangular specimens posses uniform stress levels in the wound region.
Hourglass stress distribution is not uniform, as seen in Figure 12, and possesses
a distinct stress concentration at the lateral edges of the wound.
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Figure 1 1 : Stress Contours of Rectangular Planform Specimen
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Figure 12 : Stress Contours of Hourglass Planform Specimen
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